Cargando…
Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician()
In recent years, asthma research has focused intensely on the severe part of the disease spectrum, leading to new treatments, mostly therapeutic monoclonal antibodies. However, severe asthma accounts for not more than 2% of asthma in the pediatric population. Therefore, non-severe asthma remains a m...
Autores principales: | Kalayci, Omer, Abdelateef, Hanan, Pozo Beltrán, César Fireth, El-Sayed, Zeinab A., Gómez, René Maximiliano, Hossny, Elham, Morais-Almeida, Mário, Nieto, Antonio, Phipatanakul, Wanda, Pitrez, Paulo, Wong, Gary Wk., Xepapadaki, Paraskevi, Papadopoulos, Nikolaos G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796770/ https://www.ncbi.nlm.nih.gov/pubmed/31641403 http://dx.doi.org/10.1016/j.waojou.2019.100054 |
Ejemplares similares
-
Unanswered questions on the use of biologics in pediatric asthma
por: Nieto, Antonio, et al.
Publicado: (2023) -
The role of environmental allergen control in the management of asthma
por: Kalayci, Omer, et al.
Publicado: (2022) -
Utility of biomarkers in the diagnosis and monitoring of asthmatic children()
por: Xepapadaki, Paraskevi, et al.
Publicado: (2022) -
Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2023) -
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2020)